Domov › Srpastocelična anemija › Florida
Klinične študije za Srpastocelična anemija v Florida
9 študij za Srpastocelična anemija išče udeležence na lokacijah v Florida.
Mesta v Florida
Uradno besedilo študije (angleško)
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
- University of Florida, Jacksonville
Vključevanje udeležencevFaza 3
Starost 12–100 · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT06439082A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
- Memorial Healthcare, Hollywood
Vključevanje udeležencevFaza 3
Starost 12 in več · Vsi spoli · Posodobljeno 17. sep. 2026 · NCT06612268A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
- Edward Jenner Research Group LLC., Plantation
- Pediatric Hematology / Oncology a division of Kidz Medical services, West Palm Beach
- St. Mary's Medical Center, West Palm Beach
Vključevanje udeležencevFaza 2/3
Starost 12 in več · Vsi spoli · Posodobljeno 18. avg. 2026 · NCT05431088ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- University of Florida Hemophilia Treatment Center, Gainesville
- University of Miami Comprehensive Hemophilia Treatment Center, Miami
- University of Miami Hospital and Clinics, Miami
- in še 4
Vključevanje udeležencevOpazovalna študija
Vse starosti · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT04398628Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
- Golisano Children's Hospital, Fort Myers
- The Foundation for Sickle Cell Disease, Hollywood
Vključevanje udeležencevFaza 2
Starost 12 in več · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT06699849Safety of Anumigilimab (CSL324) in Adults With Sickle Cell Disease (SCD)
- The Foundation for Sickle Cell Disease, Hollywood
Vključevanje udeležencevFaza 2
Starost 18 in več · Vsi spoli · Posodobljeno 5. avg. 2026 · NCT07224360The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
- Oncology & Hematology Associates of West Broward- Site Number : 8400029, Coral Springs
- Sylvester Comprehensive Cancer Center- Site Number : 8400020, Miami
Vključevanje udeležencevFaza 3
Starost 10–65 · Vsi spoli · Posodobljeno 29. jul. 2026 · NCT06975865Myeloablative Conditioning, Prophylactic Defibrotide and Haplo AlloSCT for Patients With Sickle Cell Disease
- University of Florida, Gainesville
Vključevanje udeležencevFaza 2
6 Months – 21 Years · Vsi spoli · Posodobljeno 27. jul. 2026 · NCT02675959A Long-term Follow-up Study in Patients Who Received BEAM-101
- Mayo Clinic Florida, Jacksonville
Vključevanje udeležencevOpazovalna študija
Starost 14–37 · Vsi spoli · Posodobljeno 28. jan. 2026 · NCT07373639Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.